• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to 8-methoxy-5-Quinolinamine (CAS No. 70945-35-6)

8-methoxy-5-Quinolinamine, identified by the Chemical Abstracts Service Number (CAS No.) 70945-35-6, is a heterocyclic organic compound belonging to the quinoline family. This compound has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its unique structural properties and potential biological activities. Quinoline derivatives, including 8-methoxy-5-Quinolinamine, have long been studied for their pharmacological significance, with many exhibiting antimicrobial, antimalarial, and anti-inflammatory properties.

The molecular structure of 8-methoxy-5-Quinolinamine features a quinoline core substituted with a methoxy group at the 8-position and an amino group at the 5-position. This specific arrangement of functional groups contributes to its distinct chemical reactivity and interaction with biological targets. The presence of the methoxy group enhances the compound's solubility in polar solvents, making it more amenable for formulation in drug delivery systems. Additionally, the amino group provides a site for further chemical modifications, enabling the synthesis of more complex derivatives with tailored biological activities.

In recent years, there has been a surge in research focused on quinoline derivatives as potential therapeutic agents. The development of novel treatments for infectious diseases, particularly those caused by resistant pathogens, has driven much of this interest. 8-methoxy-5-Quinolinamine has been investigated for its ability to modulate various enzymatic pathways and cellular processes. Preliminary studies suggest that this compound may interfere with DNA replication in certain microbial species, making it a promising candidate for further development as an antimicrobial agent.

One of the most compelling aspects of 8-methoxy-5-Quinolinamine is its potential application in the treatment of neglected tropical diseases. Many regions of the world continue to struggle with infections caused by protozoan parasites such as *Plasmodium*, the causative agent of malaria. Traditional antimalarial drugs have faced challenges due to the emergence of drug-resistant strains, necessitating the discovery of new chemotherapeutic agents. Quinoline derivatives like 8-methoxy-5-Quinolinamine offer a fresh perspective in this ongoing battle against malaria.

The synthesis of 8-methoxy-5-Quinolinamine typically involves multi-step organic reactions starting from readily available quinoline precursors. The introduction of the methoxy group at the 8-position is often achieved through nucleophilic aromatic substitution, while the amino group at the 5-position can be incorporated via reduction or direct amination techniques. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to improve yield and purity. These synthetic strategies ensure that researchers can obtain high-quality samples for both laboratory studies and potential clinical trials.

From a pharmacological standpoint, 8-methoxy-5-Quinolinamine exhibits several notable properties that make it an attractive candidate for drug development. Its ability to cross cell membranes suggests potential applications in treating intracellular pathogens. Furthermore, its structural similarity to known bioactive compounds may facilitate rapid optimization through structure-based drug design approaches. Computational modeling and molecular docking studies have been instrumental in predicting how 8-methoxy-5-Quinolinamine interacts with biological targets such as enzymes and receptors.

The safety profile of 8-methoxy-5-Quinolinamine is another critical consideration in its development as a therapeutic agent. Preliminary toxicology studies have shown that this compound exhibits moderate solubility in water and organic solvents, which can influence its absorption and distribution within biological systems. While no significant toxic effects were observed at moderate doses, further studies are necessary to assess long-term exposure risks. These assessments are essential for ensuring that any future drug candidates derived from this scaffold are safe for human use.

Recent advancements in biotechnology have opened new avenues for exploring quinoline derivatives like 8-methoxy-5-Quinolinamine. Biocatalytic methods, such as enzymatic functionalization, offer sustainable alternatives to traditional synthetic routes by reducing waste and energy consumption. Additionally, high-throughput screening technologies have enabled researchers to rapidly test thousands of compounds for their biological activity against various disease targets. These innovations are accelerating the discovery process and bringing promising candidates like 8-methoxy-5-Quinolinamine closer to clinical evaluation.

The role of 8-methoxy-5-Quinolinamine in combinatorial therapy is also an area of active investigation. By pairing this compound with other drugs that target different pathways, researchers aim to enhance overall treatment efficacy while minimizing resistance development. Such strategies are particularly relevant in combating multidrug-resistant infections where single-agent therapies often fall short. The versatility of quinoline derivatives makes them ideal candidates for combination regimens designed to address complex pathological conditions.

In conclusion,8-methoxy-5-Quinolinamine (CAS No. 70945-35-6) represents a significant advancement in pharmaceutical research due to its unique structural features and potential therapeutic applications. Its ability to modulate microbial enzymes and interfere with pathogenic processes positions it as a valuable asset in the fight against infectious diseases. As research continues to uncover new insights into its pharmacological properties,8-methoxy-5-quino linamin e holds promise not only as a standalone therapeutic agent but also as a building block for more sophisticated drug molecules designed to address unmet medical needs worldwide.

• 13207-66-4(5-Aminoquinolin-8-ol)
• 99878-77-0(4-Quinolinamine,7,8-dimethoxy-)
• 220844-65-5(8-Methoxyquinolin-4-amine)
• 75959-08-9(8-methoxyquinolin-6-amine)
• 6279-51-2(4-amino-6-methoxyquinoline)
• 75793-53-2(8-Ethoxyquinolin-5-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)